Safety and efficacy of Immune checkpoint Inhibitors (ICIs) plus chemotherapy versus chemotherapy alone for small cell lung cancer (SCLC): A systematic review and meta-analysis of randomized controlled trials

被引：0
|
作者：
Mu, Xiaohong [1 ]
Wang, Yunfang [2 ]
Fan, Zhengye [3 ]
Yi, Kang [2 ]
机构：
[1] Huanxian Peoples Hosp, Dept Cardiovasc Med, Qingyang 745700, Peoples R China
[2] Gansu Prov Hosp, Lanzhou 730000, Peoples R China
[3] First Hosp Longnan City, Longnan 742500, Peoples R China
来源：
ASIAN JOURNAL OF SURGERY | 2025年 / 48卷 / 01期
关键词：
ETOPOSIDE;
D O I：
10.1016/j.asjsur.2024.07.155
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：805 / 806
页数：2
相关论文
共 50 条
  • [41] Perioperative immune checkpoint inhibitors combined with chemotherapy versus chemotherapy for locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis of randomized controlled trials
    Huang, Danxue
    Sun, Feilong
    Ke, Liyuan
    Li, Su
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 138
  • [42] Efficacy and Safety of Immune Checkpoint Inhibitors Combined with Chemotherapy or Tyrosine Kinase Inhibitors in Advanced Endometrial Cancer: A Systematic Review and Meta-Analysis
    Li, Yuting
    Li, Shixiu
    Liang, Juan
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2024,
  • [43] A meta-analysis of randomized controlled trials comparing chemotherapy plus bevacizumab with chemotherapy alone in metastatic colorectal cancer
    Yunfei Cao
    Aihua Tan
    Feng Gao
    Lidan Liu
    Cun Liao
    Zengnan Mo
    International Journal of Colorectal Disease, 2009, 24 : 677 - 685
  • [44] A meta-analysis of randomized controlled trials comparing chemotherapy plus bevacizumab with chemotherapy alone in metastatic colorectal cancer
    Cao, Yunfei
    Tan, Aihua
    Gao, Feng
    Liu, Lidan
    Liao, Cun
    Mo, Zengnan
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2009, 24 (06) : 677 - 685
  • [45] First-line immune-checkpoint inhibitor plus chemotherapy versus chemotherapy alone for extensive-stage small-cell lung cancer: a meta-analysis
    Landre, Thierry
    Chouahnia, Kader
    Des Guetz, Gaetan
    Duchemann, Boris
    Assie, Jean-Baptiste
    Chouaid, Christos
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [46] EFFICACY AND SAFETY OF EXERCISE FOR CANCER PATIENTS RECEIVING CARDIOTOXIC CHEMOTHERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Amin, Ahmed Mazen
    Khlidj, Yehya
    Abuelazm, Mohamed
    Ibrahim, Ahmed A.
    Tanashat, Mohammad
    Imran, Muhammad
    Nazir, Abubakar
    Shaikhkhalil, Hosam Waleed
    Ibrahim, Mahmoud M.
    Abdelazeem, Basel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 2520 - 2520
  • [47] Immune Checkpoint Inhibitors Combined With Chemotherapy Compared With Chemotherapy Alone for Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
    Ji, Qiao
    Ding, Jingxian
    Hao, Meiqi
    Luo, Nachuan
    Huang, Jiabing
    Zhang, Wenxiong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [48] Immune checkpoint inhibitors in the treatment of small cell lung cancer: A systematic review and meta-analysis
    Lee, P. W. P.
    Krishnan, N.
    Boldt, G.
    Lakkunarajah, S.
    Blanchette, P.
    Raphael, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S1076 - S1076
  • [49] Checkpoint inhibitors in combination with chemotherapy for first-line treatment of advanced non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled trials (RCTs).
    Tun, Aung
    Thein, Wai Lin
    Elfiky, Aymen
    Gasperino, James
    Guevara, Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [50] Efficacy and safety of immunotherapy plus chemotherapy for lung cancer neoadjuvant treatment: A network meta-analysis based on randomized controlled trials
    Li, Shen
    Yang, Jiaqing
    Xu, Chenhao
    Ma, Xuelei
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345